AI Quick Summary

🎉We're proud to celebrate Altamira Therapeutics, resident at our Switzerland Innovation Park Basel Area - Main Campus!Altamira Therapeutics has successfully completed a public offering, raising up to USD 12 million. This funding will help advance their RNA-based therapies for cancer and rheumatoid arthritis, while also supporting the divestment of legacy assets in allergology, viral infections and inner ear disorders. We look forward to seeing their continued growth and success!👉 Read more right here: article

Post Metadata

• Author: Switzerland Innovation Digital
• Published Date: 10/7/2024 10:16:24 AM
• Modified Date: 10/7/2024 10:16:24 AM

Post Description

🎉We're proud to celebrate Altamira Therapeutics, resident at our Switzerland Innovation Park Basel Area - Main Campus!

Altamira Therapeutics has successfully completed a public offering, raising up to USD 12 million. This funding will help advance their RNA-based therapies for cancer and rheumatoid arthritis, while also supporting the divestment of legacy assets in allergology, viral infections and inner ear disorders.

We look forward to seeing their continued growth and success!

👉 Read more right here: article